Categories

Tag: Policy

POLITICS/POLICY/HEALTH PLANS: On the Blues’ political giving & CDHP complexity

Says here that Blues Plans Favor Republicans With Their 2006 Campaign Contributions. But I think what it means is that they’re favoring incumbents. Having said that and reading the polls and the tea leaves, I think the Blues might think about evening up those contributions given that the Congress is as likely to flip over his year as any since 1994, and that the Blue Dog Democrats are the crowd most traditionally aligned with their interests.

Meanwhile, Joe Paduda is showing that the CDHP is even more confusing to consumers than ordinary health plans. Well, when United bought the shysters at Golden Rule, you didn’t actually think that they were going to reform them, did you?

 

POLICY/THE INDUSTRY: Nice work if you can get it

So for rewriting Alain Enthoven’s lectures from the late 1980s and missing the main points, apparently Michael Porter is being paid $50,000 a day, and that is a discount from his apparently usual fee of $100,000! Damn, that’s nice work and yes I am very jealous. Hopefully I’ll soon have his co-author Elizabeth Teisberg on THCB to explain what I don’t understand about their book which I’m chunking through at the moment.

When I said he was sinking in the health care quagmire, I should have said that he would be rolling in it.

HOSPITALS/POLICY: Unhealthy & unhappy Returns from BillMon

I missed this but last week my favorite writer on the entire Internet, Billmon at the Whiskey Bar, wrote about health care. 99% of his posts are about foreign policy, from an extremely cynical point of view. But this time he looked at the capital problems facing hospitals and his extrapolating guess is that to maintain the profitability of hospitals we will soon be allowing emergency rooms to turf people out to die in the streets. His piece on the future of EMTALA (not that he uses the term, but he clearly understands it) is called Unhealthy Returns.

PHARMA/POLICY: Medicaid gets screwed over on best price, Ignagni fibbing again.

A little while ago I sat through a webcast starring my favorite factually challenged health plan lobbyist. Karen Ignagni said this about the costs of pharmaceuticals for Medicaid that are now bought instead by the private plans working under Part D:

"I’m hearing shock from (state) Medicaid directors that we’re getting better prices than they are"

At the time I postulated this

Ignagni is either lying here
(or massively overstating the truth from a few anecdotes), or going to
find a few men in sharp suits from the rich part of K street funded by
big Pharma coming down to see her carrying baseball bats.

You see, Medicaid plans get from pharma manufacturers
what’s known as “best price”. In other words if they give a better
price to another customer, they also have to give that price to
Medicaid. Medicaid is still of course buying its drugs for its
non-Medicare dual eligible population. The drug companies know this, so
I doubt that what she’s saying is true. But if it is true that
Ignagni’s health plan members are getting a better price than the
states are, then the states can go back to the pharma manufacturers to
get a better rebate — oh, and also prosecute Pharma companies for fraud
over not giving them best price, as has happened many times.

And today writing in the New York Times Milt Freudenheim has picked on the issue, which he calls  a Windfall From Shifts to Medicare. So was Ignagni telling the truth? Were the prices that Medicaid is now paying for its drugs via Part D lower than they were paying under the best price regime? Well take a wild guess.

Under that program, as it turns out, the prices paid by insurers, and eventually the taxpayer, for the medications given to those transferred are likely to be higher than what was paid under the federal-state Medicaid programs for the poor.

McLellan is also quoting the line that Part D is getting better prices, but the article has a raft of evidence suggesting that the drug companies think they’re doing better, and the states are being asked to return more under the "clawbacks"–the amount they are being billed as they no longer have to provide drugs for the dual eligibles–than if they’d maintained their own programs. Several states are suing the Feds about that.

Meanwhile, I still think that they ought to be able to go to the drug companies and get "best price" for the rest of their Medicaid drugs (unless someone can tell me they have an exemption under the law). Which I guess in the end may make this a wash, if the drug companies have to provide even cheaper Medicaid drugs.

But for now it’s just more evidence that Part D is a windfall for drug companies and health plans, and that AHIP’s President has been caught being extremely economical with the truth. Not exactly news, I know.

TECH/POLICY/RANDOM: Monday update

Apologies for the quiet start today. A few things to keep you going with while I work on some other stuff off-line

MyMedwork is a MySpace/Linked in for physicians which has funding from a business accelerator started by bunch of big name mid-west medical orgs (including the Cleveland Clinic). Hey I (re-)met my fiancee on Linked-In so there must be something to this social networking stuff?

The first rumblings in the real business of health care—how much Medicare pays for what—are starting up. CMS is rattling the saber, and somehow managing to divert the attention onto 3M which is attempting to redesign DRGs and getting it in the neck for its troubles, apparently. Of course this is the beginning, not the end of a very long and ongoing process. The same thing is going on on the physician side around changes in the RVS system. The health plans have been muddying this water for some time, as I noted in my article about the punking of Milt Freudenheim back in June.

I’ve been having some fun backchat with Michael Cannon at Cato (the thinking man’s libertarian think-tank) over his riposte to my piece about Medicare HSAs. Well worth reading his response. More on that when I get my act together to edit our emails…Meanwhile over at Cato’s blog you should read anything Radley Balko’s written. He’s doing the best job in America about tracking the western liberal Democracies’ almost imperceptibly slow movement towards becoming authoritarian states. Did you know that “swearing” in public in the UK can now warrant a $130 on the spot fine at the sole discretion of the police?

Finally, working on some stuff on the new San Francisco health plan, which will emerge at Spot-on soon—now that I’m banned from writing about soccer for quite some time!

 

 

POLICY/POLITICS/HEALTH PLANS: HSAs for Medicare? Crazy but apparently true

So the HSA ideology has wormed its way into CMS, and now Medicare is seeking proposals for its Consumer-Directed Health Plan demonstration. Those taxpayers who can do basic math might wonder why you’d want to to give healthy Medicare beneficiaries cash for health services that they’re not going to use, while taking that cash away from the pot that pays for the sick beneficiaries that do use said services. But we’ve asked that question so many times before and no-one on the free market side dare answer it. And I guess you might say, why not give the taxpayers money straight to the “healthys” instead of laundering it through Medicare Advantage plans as we’re doing it now so that they can hand out free gym memberships to seniors and boost their executives’ stock holdings.

But given that risk adjustment is coming to Medicare Advantage, it may be that that gravy train is ending. Perhaps we’ll get to see if the private plans really can stand on their care management merits—and there’s so much fat in Medicare that they ought to be able to, easily.  Although they failed to do so in the late 1990s.

However, it’s just bizarre to increase the costs of a tax payer funded universal risk pool by allowing people who are not paying into it to withdraw cash from it. So the only real explanation is that CMS and its political masters in the White House are eventually intending to put the entire system into a high-deductible plan and not fund the amount below the deductible.  Just the same as most employers are doing (as I explained in this Spot-on piece about Intel).  That of course makes perfect sense for the government and the taxpayer. Until, that is, the seniors find out! I wouldn’t want to be in charge of Medicare when that happens, remember what those seniors did to Rostenkowski!

POLICY/QUALITY: Reclaiming the right to die; book review by Mitchell Berger

Mitchell Berger volunteered to write a review of  William Colby’s, Unplugged: Reclaiming Our Right To Die in America (2006, American Management Association, 272 pp., $24.95 hardcover), and an excellent review it is too:

High-profile legal cases such as those involving Karen Ann Quinlan, Nancy Cruzan and Terri Schiavo and their families coupled with improvements in medical technology have forced growing numbers of patients and their family members, health care providers, judges, lawyers and legislators to confront difficult end-of-life dilemmas. Because of his own background as an attorney for the Cruzan family for four years, supporter of the hospice movement and contributor to the 1990 Patient Self-Determination Act, which requires hospitals to inform patients in writing about health care advance directives such as living wills, attorney William Colby, author of Unplugged: Reclaiming Our Right to Die in America, brings unique insights to his discussion of these cases, evolving medical technology and the overarching issue of end-of-life care in America.

Colby’s book includes an extensive discussion of the Quinlan, Cruzan and Schiavo cases. He describes how relatively recent advances in scientific knowledge, such as an improved understanding of brain function, brain death and vegetative states and advances such as cardiac defibrillators, artificial respirators, feeding tubes, percutaneous endocscopic gastronomy (PEG) tubes (a method of providing nourishment to patients using a tube inserted through an endoscopic procedure which is simpler than standard feeding tube insertion), have led to new challenges as society struggles to reconcile the benefits of these technologies with respect for the individual’s quality of life and right to live and die in a manner reflecting their beliefs. Colby devotes an entire chapter of his book to explaining the ethical and medical issues associated with feeding tubes and PEG; he explains how PEG tubes, originally intended for pediatric patients, are now used routinely in cognitively impaired elderly persons who can no longer eat on their own.

While many people would want every reasonable measure taken to prolong and maintain their life regardless of their condition, many others would not want to live in a state where they are no longer able to respond to their loved ones and the world around them. When Nancy Cruzan, then a 25-year old Missouri woman, was left in a persistent vegetative state following a car wreck in 1983, her father authorized insertion of a feeding tube. Colby explains that in a persistent vegetative state a patient may be awake and even smile or move their eyes, however these movements are completely involuntary and in fact the patient has “no thinking, no feeling, no consciousness” (p. 10). When it became clear as first months and then years went by that Nancy Cruzan would never recover from her condition, Cruzan’s family tried to act on their shared “belief that  [she] would want the feeding tube removed” (p. 89). After many years of legal proceedings both in Missouri and at the federal level, including a U.S. Supreme Court decision in 1990, the family eventually was granted the right to remove the feeding tube based on evidence of what Nancy Cruzan herself would have wanted. Extensive publicity surrounded this case – indeed the Cruzan family allowed PBS’ Frontline to document their experiences — and Colby describes how the Cruzan family’s experience altered public opinion about end-of-life care both in Missouri and elsewhere and encouraged Missouri Senator John Danforth and others to sponsor the Patient Self-Determination Act.

In perhaps the most interesting portion of his book (Chapters 1-3), Colby provides an informative and balanced discussion of the most recent and perhaps controversial end-of-life care case involving Terri Schiavo. Unlike Nancy Cruzan’s family, Schiavo’s relatives were bitterly divided about what she would have wanted and what was best for her. Colby discusses his own approach to death and dying issues and even includes his own health care power of attorney as an example for others (Chapter 10; Appendix). However, he also notes the limitations of laws and legal documents. For instance, Colby describes the “institutional glide path” which dictates that many hospital patients will receive “aggressive,” often unwanted end-of-life medical care; the “glide path” reflects the tendency of health care providers and institutions to treat patients in customary, technology-intensive ways due to such factors as medical education, institutional culture and fear of litigation.

To help ensure that the end-of-life care we receive reflects our values and desires, Colby emphasizes the importance of talking at length with family members, friends and health care providers about how we would want to be cared for if our capacity to make our own decisions should ever be impaired by illness or injury. This dialogue will help ensure that our family members and health providers are not forced to confront complex dilemmas in tense and emotional circumstances with their loved one’s wishes unclear.

Colby is a strong supporter of hospice as one option for end-of-life care. Indeed, he serves as a Senior Fellow of the National Hospice and Palliative Care Organization in Washington, D.C., and the foreword to his book is contributed by that organization’s chief executive officer. He explains the rise of hospice care, which he characterizes as a “hidden jewel,” and notes that growing numbers of patients are opting for hospice (750000 of 2.5 million Americans who died in 2005). Hospice emphasizes communication between patients, families and health care providers, symptom relief and palliative care (Chapter 15).

Though he clearly has strong opinions, Colby’s book is fair and even-handed in his treatment of the major legal and ethical issues and he includes chapters devoted to concerns about expanded recognition of the “right to die” expressed by religious organizations and persons with disabilities. The book is well-researched and well-documented, with numerous end notes, citations to outside sources, suggestions for further reading and contact information for such relevant organizations as the National Family Caregivers Association and National Institute on Aging. Overall, Colby’s book provides readers with excellent background about the key legal and scientific issues, good ideas for how to approach end-of-life care and strong motivation for initiating these sometimes awkward but critically important conversations with family members and health care providers.

POLICY: An Outcomes Primer by Eric Novack

THCB welcomes back regular contributor Dr. Eric Novack, who has something to say about outcomes as well as some recent snide comments made about orthopedic surgeons by a certain other poster on the site. In addition to blogging for THCB in his (oh so rare) free time, Eric is also the host of The Eric Novack show, which airs every Sunday on KKNT 960 AM in Phoenix. You can find an archive of his recent shows here.   

An Outcomes Primer

By ERIC NOVACK M.D.

Many in medicine view those of us in orthopedics as the ‘dumb bone doctors’Sd2 (or, according to the IV, much worse than that). Much of this stems from the basic idea that fracture care, or broken bone treatment, seems very straight-forward. Oh, but wait…

So here is a brief sense of how difficult it can be to evaluate outcomes even in the ‘simple’ area of a broken wrist. And, how it can be absurd to make the surgeon completely responsible?

The first question we need to ask is, “what outcome are we measuring”? Are
we going to look at (a) has the bone healed? (b) how ‘good’ does the
xray look- i.e. how close to ‘perfect’ are the bones lined up? (c) how
is the patient’s function, and at what point after injury do you
measure- months, years?

THCB is big on functional outcomes, so let’s just say that we care about wrist function 1 year after injury. But what kind of function? Range of motion? Return to work? Return to sports?

I’ll
make it easy and say we’ll leave that to the patient and simply ask
about satisfaction with ability to return to pre-injury functioning.

Stick
with me- I know we are looking at the easy area of a broken bone. So,
we are trying to determine functional outcomes 1 year after a wrist
fracture.

Here is one way to look at the factors impacting the outcome:

1. Patient
factors – age, motivation to get better, willingness to listen to
medical advice and follow recommendations, nutritional status, other
medical conditions, previous injuries, secondary gain issues (workers’
comp, lawsuits), body’s response to injury (i.e. inflammatory response
to trauma)

2. Injury factors—severity of injury force (e.g. trip
over dog vs. 60mph motorcycle crash), location of fracture (e.g.
involving joint cartilage), degree of displacement (i.e. how ‘bad’ the
xray looks), associated soft tissue injuries, associated injuries
impacting treatment and rehab decisions

3. Surgeon
factors—appropriate decision making, surgical technical skill,
doctor-patient communication (discussing injury, options, risks, and
expectations)

Rhetorically (and not), I ask- how much of the outcome can the surgeon possibly control?

The
answer, of course, is only the ‘surgeon factors’, which I will claim
generally make up a relatively small piece of the total outcome pie.

So
I say again (and again)- until I can get some converts… the future of
quality improvement lies not in just trying to identify ‘best
practices’ that can be difficult to prove and identify and can change
every few years—but rather in identifying what are the WRONG approaches
for conditions (much easier to get agreement here), and emphasizing the
importance of communicating appropriate expectations to patients.

assetto corsa mods